The costs of an expanded screening criteria for COVID-19: A modelling study
Author(s) -
Jue Tao Lim,
Borame Sue Lee Dickens,
Alex R. Cook,
Ai Leng Khoo,
Yock Young Dan,
Dale Fisher,
Paul Anantharajah Tambyah,
Louis Yi Ann Chai
Publication year - 2020
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2020.08.025
Subject(s) - medicine , covid-19 , outbreak , isolation (microbiology) , health care , total cost , cost–benefit analysis , emergency medicine , medical emergency , disease , intensive care medicine , infectious disease (medical specialty) , business , pathology , ecology , accounting , microbiology and biotechnology , economics , biology , economic growth
Nosocomial infection is an ongoing concern in the COVID-19 outbreak. The effective screening of suspected cases in the healthcare setting is therefore necessary, enabling the early identification and prompt isolation of cases for epidemic containment. We aimed to assess the cost and health outcomes of an extended screening strategy, implemented in Singapore on 07 February 2020, which maximizes case identification in the public healthcare system.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom